+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Healthcare Licensing - Country Trends: Germany Mid-Year Review

  • ID: 4604811
  • Report
  • July 2018
  • Region: Global, Germany
  • 120 pages
  • FinGlobe, Inc
1 of 2
This mid-year review report brings at one place all the news for licensing deals and negotiations that took place between healthcare companies of Germany and other countries worldwide during January 1, 2018 to June 30, 2018. The licensing trends and directions during this time period are also analyzed comprehensively.

Key Features:
  • 6 months’ Germany healthcare licensing news at one place
  • Small, medium and big multinational/non-multinational companies covered
  • Curated categorizations of licensing news
  • 8+ variables reflecting different forms of transactions done
  • Licensing trends and directions summarized
The Report is useful to:
  • Germany and other countries’ healthcare companies planning to introduce products in each other’s markets
  • Companies active in R&D and seeking new market base
  • Healthcare company executives negotiating licensing deals between Germany and other countries worldwide
  • Investors analyzing varied kinds of transaction options for licensing deals
Key analysis provided: January-June 2018
  • Total number of licensing deals from Germany companies to other countries’ companies
  • Total number of licensing deals from other countries’ companies to Germany companies
  • Total number of companies/institutes involved in Germany licensing deals
  • Most licensing deals signed by companies of which sub-industry within healthcare sector
  • Most licensing deals signed by which market capitalization group’s companies
  • Most licensing deals signed by which medicine groups
  • Licensing payment arrangements most followed in the licensing deals between Germany and other countries’ companies
  • Number of domestic and worldwide licensing between Germany and other countries’ companies
  • Number of R&D and commercialization licensing between Germany and other countries’ companies
  • Number of licensing deals discontinued between Germany and other countries’ companies
Note: Product cover images may vary from those shown
2 of 2
Introduction

Research Design

Section 1: Healthcare inventions licensed by Germany to Other Countries
1.1 By Germany company name
1.2 By Other country company name
1.3 By Sub-industry
1.4 By Market capitalization groups
1.5 By Terms of payment
1.6 By Medical groups

Section 2: Healthcare inventions licensed by Other Countries to Germany
2.1 By Other country company name
2.2 By Germany company name
2.3 By Sub-industry
2.4 By Market capitalization groups
2.5 By Terms of payment
2.6 By Medical groups

Section 3: Healthcare inventions licensed within Germany

Section 4: Trends in Germany healthcare licensing deals
4.1 Healthcare sub-sector with most licensing deals
4.2 Market capitalization groups with most licensing deals
4.3 Healthcare companies most active in outbound and inbound licensing deals
4.4 Medical groups most active in licensing deals
4.5 Licensing payment arrangements most followed
4.6 Worldwide licensing vs domestic licensing
4.7 R&D licensing vs commercialization licensing
4.8 Licensing deals which discontinued

Section 5: Trends and directions

Appendices
Appendix 1 List of Germany-based companies/institutes covered in this report
Appendix 2 List of other countries’ companies/institutes covered in this report
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll